ArticleAsian journal of pharmaceutical sciences2022

Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin.

Canyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.